PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation

Por Seront, E, Pinto, A, Bouzin, C, Bertrand, L, Machiels, J-P, Feron, O
Publicado em 2013

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

Por Seront, E, Boidot, R, Bouzin, C, Karroum, O, Jordan, B F, Gallez, B, Machiels, J-P, Feron, O
Publicado em 2013

Cancer and renal insufficiency results of the BIRMA study

Por Janus, N, Launay-vacher, V, Byloos, E, Machiels, J-P, Duck, L, Kerger, J, Wynendaele, W, Canon, J-L, Lybaert, W, Nortier, J, Deray, G, Wildiers, H
Publicado em 2010

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial(...

Por Clement, P. M., Gauler, T., Machiels, J. P., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Cohen, E. E. W., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., del Campo, J. M., Cong, X. J., Ehrnrooth, E., Vermorken, J. B.
Publicado no Ann Oncol (2016)